Skip to main content

People in the News: Matthias Mann; Nick McCooke; and More

Premium

The Swiss Louis-Jeantet Foundation this week awarded Matthias Mann its Louis-Jeantet Prize in recognition of his work on protein biomarkers for use as cancer diagnostics.

A director at the Max Planck Institute of Biochemistry in Martinsried, Mann is the developer of a number of widely used proteomics techniques and platforms, including the SILAC protein labeling method and the MaxQuant bioinformatics software. The prize comes with an award of approximately €580,000 ($765,000).


Pronota CEO and board member Nick McCooke is stepping down to pursue opportunities closer to his home in the UK. He is being replaced Katleen Verlseysen, who was previously the company's chief operating officer.

The company also announced that chairman of the board John Berriman is stepping down and will be replaced by Rudy Dekeyser, managing director of VIB.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.